Journal of Medicinal Chemistry
Volume 43, Issue 10 (May 18, 2000)
Copyright © 2000 American Chemical Society

Click [Full Article - PDF] to display or print the full article page image in PDF. Note: As of August 2000, Acrobat Reader 4.0 or later is recommended for PDFs.

ARTICLES

1901-1909

Application of Similarity Matrices and Genetic Neural Networks in Quantitative Structure-Activity Relationships of 2- or 4-(4-Methylpiperazino)pyrimidines: 5-HT2A Receptor Antagonists Tomasz Borowski, Marcin Król, Ewa Brocawik, Timothy C. Baranowski, Lucjan Strekowski, and Maria J. Mokrosz [Full Article - PDF]

1910-1926

Design and Synthesis of Cyclopenta[g]quinazoline-Based Antifolates as Inhibitors of Thymidylate Synthase and Potential Antitumor Agents Vassilios Bavetsias, Jonathan H. Marriott, Camille Melin, Rosemary Kimbell, Zbigniew S. Matusiak, F. Thomas Boyle, and Ann L. Jackman [Full Article - PDF]

1927-1939

Synthesis and Evaluation of "AZT-HEPT", "AZT-Pyridinone", and "ddC-HEPT" Conjugates as Inhibitors of HIV Reverse Transcriptase Renée Pontikis, Valérie Dollé, Jean Guillaumel, Elsa Dechaux, Reine Note, Chi Hung Nguyen, Michel Legraverend, Emile Bisagni, Anne-Marie Aubertin, David S. Grierson, and Claude Monneret [Full Article - PDF]

1940-1948

1,3,5-Trialkyl-2,4,6-triiodobenzenes: Novel X-ray Contrast Agents for Gastrointestinal Imaging Kimberly G. Estep,,2 Kurt A. Josef, Edward R. Bacon,2 Carl R. Illig,2 John L. Toner,2 Dinesh Mishra, William F. Blazak, Dennis M. Miller,4 David K. Johnson, Jack M. Allen, Andy Spencer,4 and Susan A. Wilson4 [Full Article - PDF]

1949-1957

Modeling of the Inhibition of Retroviral Integrases by Styrylquinoline Derivatives Mohammed Ouali, Cyril Laboulais, Hervé Leh, David Gill, Didier Desmaële, Khalid Mekouar, Fatima Zouhiri, Jean d'Angelo, Christian Auclair, Jean-François Mouscadet, and Marc Le Bret [Full Article - PDF]

1958-1968

4-Alkyl- and 4-Cinnamylglutamic Acid Analogues Are Potent GluR5 Kainate Receptor Agonists Concepción Pedregal, Iván Collado, Ana Escribano, Jesús Ezquerra, Carmen Domínguez, Ana I. Mateo, Almudena Rubio, S. Richard Baker, John Goldsworthy, Rajender K. Kamboj, Barbara A. Ballyk, Ken Hoo, and David Bleakman [Full Article - PDF]

1969-1974

Design, Synthesis, and Preliminary Pharmacological Evaluation of 1,4-Diazabicyclo[4.3.0]nonan-9-ones as a New Class of Highly Potent Nootropic Agents Dina Manetti, Carla Ghelardini, Alessandro Bartolini, Cristina Bellucci, Silvia Dei, Nicoletta Galeotti, Fulvio Gualtieri, Maria Novella Romanelli, Serena Scapecchi, and Elisabetta Teodori [Full Article - PDF]

1975-1985

A Novel Approach for the Virtual Screening and Rational Design of Anticancer Compounds Ernesto Estrada, Eugenio Uriarte, Alina Montero, Marta Teijeira, Lourdes Santana, and Erik De Clercq [Full Article - PDF]

1986-1992

Biosensor Analysis of the Interaction between Immobilized Human Serum Albumin and Drug Compounds for Prediction of Human Serum Albumin Binding Levels Åsa Frostell-Karlsson, Annika Remaeus, Håkan Roos, Karl Andersson, Peter Borg, Markku Hämäläinen, and Robert Karlsson [Full Article - PDF]

1993-2006

Quantized Surface Complementarity Diversity (QSCD): A Model Based on Small Molecule-Target Complementarity Edward A. Wintner and Ciamac C. Moallemi [Full Article - PDF]

2007-2018

SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues Maurizio Recanatini, Andrea Cavalli, Federica Belluti, Lorna Piazzi, Angela Rampa, Alessandra Bisi, Silvia Gobbi, Piero Valenti, Vincenza Andrisano, Manuela Bartolini, and Vanni Cavrini [Full Article - PDF]

2019-2030

Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers, Lisa A. Gearhart, Nicholas A. Magnus, Lee T. Bacheler, Sharon Diamond, Susan Jeffrey, Ronald M. Klabe, Beverly C. Cordova, Sena Garber, Kelly Logue, George L. Trainor, Paul S. Anderson, and Susan K. Erickson-Viitanen [Full Article - PDF]

2031-2039

A New Class of HIV-1 Integrase Inhibitors: The 3,3,3',3'-Tetramethyl-1,1'-spirobi(indan)-5,5',6,6'-tetrol Family Valentina Molteni, Denise Rhodes, Kathleen Rubins, Mark Hansen, Frederic D. Bushman, and Jay S. Siegel [Full Article - PDF]

2040-2048

Novel Antiarthritic Agents with 1,2-Isothiazolidine-1,1-dioxide (-Sultam) Skeleton: Cytokine Suppressive Dual Inhibitors of Cyclooxygenase-2 and 5-Lipoxygenase Masanao Inagaki, Tatsuo Tsuri, Hirokuni Jyoyama, Takashi Ono, Katsutoshi Yamada, Mika Kobayashi, Yozo Hori, Akinori Arimura, Kiyoshi Yasui, Kouji Ohno, Shinji Kakudo, Kenzo Koizumi, Ryuji Suzuki, Miyako Kato, Shinichi Kawai, and Saichi Matsumoto [Full Article - PDF]

2049-2063

Discovery of Novel, Potent, and Selective Small-Molecule CCR5 Antagonists as Anti-HIV-1 Agents: Synthesis and Biological Evaluation of Anilide Derivatives with a Quaternary Ammonium Moiety Mitsuru Shiraishi, Yoshio Aramaki, Masaki Seto, Hiroshi Imoto, Youichi Nishikawa, Naoyuki Kanzaki, Mika Okamoto, Hidekazu Sawada, Osamu Nishimura, Masanori Baba, and Masahiko Fujino [Full Article - PDF]

2064-2071

Novel Conformationally Constrained Tropane Analogues by 6-endo-trig Radical Cyclization and Stille Coupling - Switch of Activity toward the Serotonin and/or Norepinephrine Transporter Alexander Hoepping, Kenneth M. Johnson, Clifford George, Judith Flippen-Anderson, and Alan P. Kozikowski [Full Article - PDF]

BRIEF ARTICLES

2072-2078

Structure-Activity Study on the in Vitro Antiprotozoal Activity of Glutathione Derivatives Claudius D'Silva and Sylvie Daunes , Peter Rock, Vanessa Yardley, and Simon L. Croft [Full Article - PDF]

2079-2081

7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: A New Heterocyclic System and a New Lead Compound for Dopamine Receptor Antagonists Thomas Witt, Franz J. Hock, and Jochen Lehmann [Full Article - PDF]

BOOK REVIEWS

2082-2082

Combinatorial Chemistry and Technology. Principles, Methods, and Applications Edited by Stanislav Miertus and Giorgio Fassina. Marcel Dekker, New York. 1999. xii + 435 pp. 16 x 23.5 cm. ISBN 0-8247-1960-3. $165.00. Robert G. Gentles [Full Article - PDF]